CN113637716A - Preparation method of alpha-glucan oligosaccharide - Google Patents
Preparation method of alpha-glucan oligosaccharide Download PDFInfo
- Publication number
- CN113637716A CN113637716A CN202110939430.XA CN202110939430A CN113637716A CN 113637716 A CN113637716 A CN 113637716A CN 202110939430 A CN202110939430 A CN 202110939430A CN 113637716 A CN113637716 A CN 113637716A
- Authority
- CN
- China
- Prior art keywords
- alpha
- glucan
- culture medium
- oligosaccharide
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940064062 alpha-glucan oligosaccharide Drugs 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 41
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 37
- 108090000790 Enzymes Proteins 0.000 claims abstract description 31
- 102000004190 Enzymes Human genes 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 241001506991 Komagataella phaffii GS115 Species 0.000 claims abstract description 13
- 229920002307 Dextran Polymers 0.000 claims abstract description 11
- 238000005374 membrane filtration Methods 0.000 claims abstract description 5
- 238000004108 freeze drying Methods 0.000 claims abstract description 3
- 241000221955 Chaetomium Species 0.000 claims abstract 2
- 230000035484 reaction time Effects 0.000 claims abstract 2
- 239000001963 growth medium Substances 0.000 claims description 25
- 239000013612 plasmid Substances 0.000 claims description 18
- 229920001503 Glucan Polymers 0.000 claims description 11
- 229920000310 Alpha glucan Polymers 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 108010058643 Fungal Proteins Proteins 0.000 claims description 5
- 241000235058 Komagataella pastoris Species 0.000 claims description 5
- 239000013613 expression plasmid Substances 0.000 claims description 5
- 239000013600 plasmid vector Substances 0.000 claims description 5
- 238000011426 transformation method Methods 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 5
- 101100364969 Dictyostelium discoideum scai gene Proteins 0.000 claims description 4
- 101100364971 Mus musculus Scai gene Proteins 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000011218 seed culture Methods 0.000 claims description 4
- 108010001682 Dextranase Proteins 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 2
- 108010080698 Peptones Proteins 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 235000019319 peptone Nutrition 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims 9
- 108091008146 restriction endonucleases Proteins 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 abstract description 8
- 238000000926 separation method Methods 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 238000006731 degradation reaction Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 230000000593 degrading effect Effects 0.000 abstract description 2
- 238000005265 energy consumption Methods 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000005260 corrosion Methods 0.000 abstract 1
- 230000007797 corrosion Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012137 tryptone Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 241000002306 Collariella gracilis Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of oligosaccharide preparation, and particularly relates to a method for preparing alpha-glucan oligosaccharide by an enzyme method. The alpha-D-dextranase gene SEQ ID NO.1 extracted from chaetomium elegans is introduced into pichia pastoris GS115 for expression, then the dextran enzyme obtained by separation is used for degrading the low molecular weight dextran, the synthesis of alpha-glucan oligosaccharide is controlled by controlling the addition amount and the reaction time of the enzyme, and then the alpha-glucan oligosaccharide with the molecular weight of about 1kDa is obtained by membrane filtration and freeze drying. The traditional acid degradation method has the problems of high energy consumption rate, high chloride residue, easy corrosion of equipment and the like. The method has the advantages of controllable reaction, simple process, high utilization rate of raw materials and the like, and the product of the method is uniform and does not produce reducing monosaccharide.
Description
Technical Field
The invention belongs to the technical field of oligosaccharide preparation, and particularly relates to a preparation method for preparing alpha-glucan oligosaccharide by an enzyme method.
Background
Oligosaccharides are low-polymerization degree saccharides which are polymerized from 2 to 9 monosaccharides and are linked to form a linear chain or a linear chain through glycosidic bonds, and are also called oligosaccharides, and the molecular formula of the oligosaccharides can be generally expressed as (C6H10O5) n (n is 2-9), and the molecular weight of the oligosaccharides is about 300-. The unique structure of the oligosaccharide makes the oligosaccharide have obvious difference with monosaccharide and polysaccharide in the aspects of physicochemical properties, physiological functions and the like. The oligosaccharide and the derivatives thereof are important substances with biological activity, can promote the growth of bifidobacterium, have the characteristics and functions of low calorie, tooth decay resistance, tumor resistance, diabetes prevention and the like, and recently research shows that the oligosaccharide also has the effects of anticoagulation, oxidation resistance, immune system regulation and the like.
Oligosaccharides are ubiquitous in plants in various ways, most of the plants contain more oligosaccharides and similar substances in fruits and seeds, and monosaccharides constituting the oligosaccharides mainly comprise xylose, galactose, glucose, arabinose, fructose and the like. There are thousands of oligosaccharides that have been identified, and they can be classified into homo-oligosaccharides and hetero-oligosaccharides according to the difference in monosaccharides that constitute the oligosaccharides, the homo-oligosaccharides being oligosaccharides polymerized from the same monosaccharide, and the hetero-oligosaccharides being oligosaccharides polymerized from two or more different types of monosaccharides. The alpha-glucan oligosaccharide is homooligosaccharide formed by polymerizing 2-9 glucose monomers, has various biological activities of the oligosaccharide, and is widely applied to the fields of food, medicine, cosmetics and the like.
At present, the industrial preparation method of the alpha-glucan oligosaccharide mainly degrades glucan with high molecular weight into oligosaccharide with lower molecular weight by acid or ultrasonic wave, and the glucanase is used for reducing the viscosity of the polysaccharide in the sugar industry, and no relevant literature research is found for preparing the glucan oligosaccharide. Compared with an acid method and an ultrasonic degradation method, the method for producing glucan oligosaccharide by enzyme catalysis has the advantages of mild enzyme catalysis reaction, easier process control, lower equipment requirement and less energy consumption. And the alpha-glucanase has certain selectivity when degrading the glucan with large molecular weight, and when the molecular weight is less than a certain amount, the glucan oligosaccharide can not be degraded any more, so that the molecular weight of the glucan oligosaccharide product prepared by the enzyme method is more uniform. The method provides experience for realizing large-scale preparation of glucan oligosaccharide by an industrial enzyme method.
Disclosure of Invention
The purpose of the invention is: provides a method for preparing alpha-glucan oligosaccharide by an enzyme method. The method has the advantages of simple and controllable process, high preparation efficiency of the alpha-glucan oligosaccharide, small influence on the structure and biological activity of the alpha-glucan oligosaccharide, realization of separation and mass preparation of oligosaccharide mixtures, and possibility of enzyme preparation for industrial production of the alpha-glucan oligosaccharide.
The preparation method of the alpha-glucan oligosaccharide comprises the following steps:
(1) integrating the alpha-D-dextranase gene as shown in SEQ ID NO.1 to a yeast protein expression plasmid vector to obtain a recombinant plasmid vector containing a target gene;
(2) preparation ofE.coli Dh5 α competence;
(3) introducing the plasmid containing the alpha-D-dextranase gene obtained in the step (1) intoE.coli Dh5 α;
(4) subjecting the product obtained in step (3)E.coliDh5 alpha, and then cultured fromE.coliExtracting plasmids from Dh5 alpha;
(5) linearizing the plasmids extracted in the step (4);
(6) preparing pichia pastoris GS115 competence;
(7) introducing the linearized plasmid obtained in the step (5) into pichia pastoris GS 115;
(8) fermenting and culturing the pichia pastoris GS115 containing the alpha-D-dextranase gene obtained in the step (7), and centrifuging to obtain a crude enzyme solution of dextranase;
(9) mixing the crude enzyme solution obtained in the step (8) with a dextran solution with low molecular weight according to a certain proportion for reaction;
(10) performing membrane filtration on the reaction liquid reacted for a certain time in the step (9) to obtain a solution of alpha-glucan oligosaccharide;
(11) and (3) carrying out rotary evaporation concentration and freeze drying on the solution of the alpha-glucan oligosaccharide obtained in the step (10) to obtain the alpha-glucan oligosaccharide with the molecular weight of about 1 k.
Wherein:
the alpha-D-dextranase gene in the step (1) is derived from Chaetomium gracile (with the number of CGMCC 3.3783).
The yeast in the step (1) is pichia pastoris GS115, and the yeast protein expression plasmid vector is pPIC9 k.
The culture medium used for the E.coli Dh5 alpha expansion culture in the step (4) is LB culture medium. The LB culture medium formula is: 10g/L of tryptone and 5g/L, NaCl10g/L of yeast powder.
The enzyme used for the linearization described in step (5) is abbreviated as ScaI.
The introduction method in the step (7) is an electrical transformation method of pichia pastoris, the electric shock condition is 2000V, 200 omega and 25 muF, and the discharge time is 4.9 ms.
The strain activation culture medium used in the fermentation culture in the step (8) is a yeast extract peptone glucose culture medium, YPD culture medium for short, the seed culture medium is BMGY culture medium, and the fermentation culture medium is BMMY culture medium.
The molecular weight of the low molecular weight dextran in the step (9) is about 8kDa, and the dextran is prepared in the early stage of a laboratory.
The filter membrane used in the membrane filtration in the step (10) is a filter membrane with the pore size capable of intercepting 1k of molecular weight.
Compared with the prior art, the invention has the following beneficial effects:
the preparation method for preparing the alpha-glucan oligosaccharide by the enzyme method has the advantages of simple and controllable process, high preparation efficiency, small influence on the structure and biological activity of the alpha-glucan oligosaccharide, no generation of reducing monosaccharide and realization of efficient separation of the alpha-glucan oligosaccharide.
Drawings
FIG. 1 is a high performance liquid chromatogram of a low molecular weight glucan substrate and glucan oligosaccharide product of the invention.
FIG. 2 is a Fourier infrared spectrum of the product of the invention, alpha-glucan oligosaccharides.
FIG. 3 is the NMR spectrum of the product of the present invention, alpha-glucan oligosaccharide.
FIG. 4 is a carbon spectrum of the product of the present invention, alpha-glucan oligosaccharide.
Detailed Description
The present invention is further described below with reference to examples.
Example 1
The method for constructing the dextran enzyme-producing engineering bacteria described in this embodiment 1 includes the following steps:
constructing a recombinant plasmid expression vector containing a target gene;
amplifying and linearizing the recombinant plasmid expression vector;
preparing pichia pastoris GS115 competence;
introducing the linearized recombinant plasmid vector into pichia pastoris GS 115;
the target gene in the step (1) is derived from an alpha-D-dextranase gene of Chaetomium gracile (with the number of CGMCC 3.3783), and is shown as SEQ ID NO. 1.
The yeast protein expression plasmid vector in the step (1) is pPIC9 k. The alpha-D-dextranase gene was inserted between the SnaB I and EcoRI cleavage sites of pPIC9k and was synthesized by Kinsley.
The recombinant plasmid expression vector amplification method in the step (2) is to introduce the recombinant plasmid into Escherichia coli Dh5 alpha and amplify the recombinant plasmid expression vector by culturing Dh5 alpha. Preparing an LB culture medium: 10g/L of tryptone and 5g/L, NaCl10 g/10 g/L of yeast powder. Dh5 α transformation experiments: mu.l of the recombinant plasmid vector was added to a centrifuge tube containing Dh 5. alpha. competent cells. After ice-cooling for 20min, water bath at 42 ℃ is carried out for 90s, and ice-cooling is carried out for 5 min. Adding 800 μ lLB culture medium, shaking at 37 deg.C and 60r/min, and warm bathing for 45 min. 150 ampicillin-resistant LB plates were plated and incubated overnight at 37 ℃.
The enzyme used for linearization of the recombinant plasmid expression vector in step (2) is ScaI. And (3) plasmid extraction: after overnight culture of E.coli Dh5 α containing the recombinant plasmid expression vector, plasmids were extracted according to the plasmid miniprep kit. Linearization experiment: the enzyme digestion reaction system comprises 2000ng of recombinant plasmid vector, ScaI 2. mu.l, 10 × L5. mu.l and ddH2O, the total volume is 50. mu.l, and the reaction is carried out for 3h at 37 ℃. After the reaction is finished, whether the linearization is complete is detected through gel electrophoresis, and a small amount of agarose gel recovery kit is used for recovering the linearized expression vector fragments.
The preparation method of pichia pastoris GS115 competence in the step (3) is the preparation of competent cells by an electrical transformation method. Preparation of YPD Medium: 22g/L glucose, 10g/L yeast powder, 20g/L tryptone, 115 ℃ and 20min for sterilization for later use. Preparing pichia pastoris competent cells: 50 mul of Pichia pastoris original strain is inoculated into a 5mL YPD test tube, and the strain grows overnight at 30 ℃ and 200 rpm; then taking 150 mul, transferring to a 250mL PYD shake flask, culturing at 30 ℃ and 200rpm until the OD600 is 1.3-1.5, transferring the bacterial liquid in the shake flask to a 100mL centrifuge tube, centrifuging at 4 ℃ and 5000rpm for 10min, pouring off the supernatant, and then re-suspending the cells by using 50mL precooled sterile double distilled water; centrifugation as above, after removal of the supernatant, the cells were resuspended in 25 ml of pre-cooled sterile double distilled water; centrifugation as above, decanting the supernatant and resuspending the cells with 4ml of pre-cooled 1M sorbitol; centrifugation as above, decanting the supernatant and resuspending the cells with 100. mu.l of pre-cooled 1M sorbitol; the prepared competent cells were dispensed into 1.5ml EP tubes per 60. mu.l.
The transformation method in the step (4) is an electric transformation method. Pichia pastoris GS115 electrotransformation experiment: mixing 60 mul of yeast competent cells with 10-15 mul of linearized fragments with the concentration of 200ng/ml, and transferring into a precooled 0.2cm3 electric transfer cup; placing on ice for 5min, and then clicking, wherein the electric shock condition is 2000V, 200 omega and 25 muF, and the discharge time is 4.9 ms; immediately adding 1ml of precooled 1M sorbitol into an electric rotating cup after electric shock, and transferring the content into a sterilized centrifuge tube; standing for 2h at 30 ℃; and taking 100 mul of a geneticin G418YPD plate, and picking a single colony for verification in 3-4 days.
Example 2 fermentation experiment of engineering bacteria for producing dextranase
Preparing a seed culture medium BMGY: 10g/L of yeast powder, 20g/L of tryptone, K2HPO42.23g/L, KH2PO4g/L, 10ml/L, YNB 134g/L of glycerol, 4 x 10-5g/L of biotin and 10g/L of histidine.
Preparing a fermentation medium BMMY: 10g/L yeast powder, 20g/L tryptone, K2 HPO42.23g/L, KH2PO4g/L, YNB 134g/L biotin 4 x 10-5g/L histidine 10g/L and 2% methanol.
Defining enzyme activity: the amount of 1. mu. mol glucose produced by degradation of the substrate per ml of enzyme solution in 1 min.
And (3) enzyme activity detection experiment, namely taking acetic acid-sodium acetate buffer solution with pH of 5 as a solvent, and preparing dextran TB7 into sugar solution with mass fraction of 3%. 100 μ l of the crude enzyme solution and 900 μ l of the prepared sugar solution were mixed in a 2ml centrifuge tube and reacted in a 55 ℃ water bath for 15 min. After the reaction, 100. mu.l of the reaction mixture was put into a 5ml centrifuge tube, 300. mu.l of water and 300. mu.l of DNS solution were added thereto, boiled for 5min, and diluted to 4ml with water. Reading is detected by an ultraviolet spectrophotometer at the wavelength of 540nm, and the enzyme activity is calculated by a standard curve.
Fermentation experiment: inoculating 50ml of recombinant Pichia pastoris engineering bacteria stored at-80 ℃ into a 5ml YPD test tube; after culturing for 16h, inoculating 500 μ l of the mixture to 50ml of seed culture medium BMGY for culturing; when the OD600 of the seed liquid is 4-5, transferring the bacterial liquid into a sterilized 100ml centrifugal tube, and centrifuging at 4 ℃ and 6000rpm for 10 min; pouring out the supernatant, re-suspending the thallus with partial BMMY culture medium, transferring to 100ml fermentation culture medium, fermenting at 30 deg.C and 200rpm, detecting thallus concentration and enzyme activity every day, and stopping fermentation when the enzyme activity increase amplitude is not obvious; centrifuging at 4 deg.C and 8000rpm for 10min, and collecting supernatant as crude enzyme solution for catalysis.
Example 3
The method for preparing alpha-glucan oligosaccharide described in example 3 consists of the following steps:
(1) mixing the crude enzyme solution obtained by centrifuging the fermentation liquor and dextran TB7 concentrated solution with molecular weight of about 8kDa prepared in the early stage of a laboratory in a reaction container for reaction.
(2) After the reaction, the reaction solution was taken out and separated and purified.
(3) Concentration and crystallization.
The reaction system in the reactor in the step (1) is 450ml of crude enzyme solution with the mass fraction of 10% dextran TB 7500 ml, the mass fraction of 250ml of acetic acid-sodium acetate buffer solution and the enzyme activity of 13U/ml, and the total volume is 1.2L. The enzyme activity concentration of the whole catalytic system is 5U/L, the pH value is adjusted to 5.0, and the reaction is carried out for 4 hours at the temperature of 55 ℃.
The separation and purification experiment in the step (2) is as follows: the reaction solution was taken out of the reaction vessel and boiled for 10min to denature the proteins in the reaction solution, and the residual cells, denatured proteins and some other solid insoluble matter in the reaction solution were removed by filtration through a microfiltration membrane. Removing some protein molecules and glucan with large molecular weight by using an ultrafiltration membrane capable of intercepting 5kDa through membrane pores, and collecting the permeate containing the alpha-glucan oligosaccharide.
The concentration operation described in step (3) is to evaporate most of the water by a rotary evaporator to concentrate the α -glucan oligosaccharide solution. Freezing and crystallizing the concentrated alpha-glucan oligosaccharide solution, putting the solution into a freezing vacuum drier for 2 days, and grinding the solution into powder. The total yield of oligosaccharide was calculated to be 65.65%.
Sequence listing
<110> Nanjing university of industry
<120> preparation method of alpha-glucan oligosaccharide
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1788
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
aattacccat tgcccccagt acgatacgtc tatgtccaac tgacccaagg agtcagactg 60
gaagttactc atagtcactt gctcgccgcc tacagtccaa ttacttatcg ccacgccaaa 120
tttaagaccg gaggacgccg gcacaattga cttcccggtg cctatgctat tagcttgtag 180
gccgtccgga aacgcgacgt tttggatacg aaagtctctg tagttttgca ggggagtaat 240
tctcattaga gctggacaca aaccctcgca gactagatta ctgattgtca ttgaaataga 300
tttagcggga tcgaccgaac gaccaggcat gtagaatggt gacgctccga ttatggcgga 360
gggaacgtag gtctcacttt ttatgtagcg cgtatgaata atatacaggt cctgtaacgt 420
gacaccggtg acgtccctgg tatcccatcc catctggata atcgggtcgt tatgtgcctt 480
ccatatagta gcacgtgtta cggttacccc actgtaatac gtctttatcg catcatcgtt 540
cacgtgatag aacacgtcgt ggacctgact attaggatac atctgagggc catccgtctg 600
gaagaaaaat gcgccgactt gtttataatc ggatatccga gttgtgatgt cgcttgaccc 660
atgaaaatcc attgtattaa acgggggtgc atttatggtc gggccttgac aataccacgt 720
ttgtccacca cctaggttat tatgccacca catcctgaga cttgtcgcat cacttttcag 780
tgcttggtag taagttgcag ggttggcctg gtatacataa tgctctccac ttagcacccc 840
gtgaccagtt gcgtaaaagt cggatttggt tgagtactca atggcccctt tcacgtacgc 900
accgggcgcg aggtaggccc aatatgtgtt cggatgtaac ctgatgtgat tttcgcctat 960
cttaggcgtc tgcccttgct ggttagagtt catccaataa accccgggtg ggaaatataa 1020
gattccgcta gatccccagt caccttgatt aataggacct ggagtcatga cctttgtgtc 1080
tggcccatcg attcgtggca ccatattgtc tggcagaaac ggtgatgcga agataaccaa 1140
ggcgttgcga ggttcaactc ccacgatgga tcctcccgaa gaaacatagc gcgacccatc 1200
gctgcgataa gtataaagat cattatcaaa ttctacagag aaccgtcgac cgttagggtc 1260
gtgtggaacc cgaatcacaa tgccgccgtc gctcgaagat cgtatatcat acgagatagc 1320
tgttggtcta attttaactc cggagggatc aggcaagcga gacccatccc gggtcaggat 1380
ctttacgtct accccggtgg aatattcaaa ctggctccaa gccatgttta ttccagcact 1440
cgtttcaatt gtgattccgt catcgacatc gctgccgaga gtgtccgaat tggggggatc 1500
ccacggagaa tatatccggc ctctcccgtt tcgagggata gattcatatg cgaatgaatc 1560
gtagaaatca tttacaccag caatgctaac ttggaccaag tacttgtgag actgcctcac 1620
atttcctaac tgaaccatgc tggcagtgtt tatctcgcca ttgtcgtgcc accatgtgca 1680
gagttgactg ttgcagaccg tatggttccc ggccctctga cggattgcat ggccaacggt 1740
cggttgaaat aagagccatc caagaagaac ggccgaaaac attacgta 1788
Claims (10)
1. A method for preparing alpha-glucan oligosaccharide by an enzyme method is characterized by comprising the following steps: the method comprises the following steps:
(1) integrating the alpha-D-dextranase gene as shown in SEQ ID NO.1 to a yeast protein expression plasmid vector to obtain a recombinant plasmid vector containing a target gene;
(2) preparation ofE.coliDh5 α competence;
(3) introducing the plasmid containing the alpha-D-dextranase gene obtained in the step (1) intoE.coliDh5 α;
(4) subjecting the product obtained in step (3)E.coliDh5 alpha, and then cultured fromE.coli Extracting plasmids from Dh5 alpha;
(5) linearizing the plasmids extracted in the step (4);
(6) preparing pichia pastoris GS115 competence;
(7) introducing the linearized plasmid obtained in the step (5) into pichia pastoris GS 115;
(8) fermenting and culturing the pichia pastoris GS115 containing the alpha-D-dextranase gene obtained in the step (7), and centrifuging to obtain a crude enzyme solution of dextranase;
(9) mixing the crude enzyme solution obtained in the step (8) with a dextran solution with low molecular weight according to a proportion for reaction;
(10) performing membrane filtration on the reaction solution in the step (9) to obtain a solution of alpha-glucan oligosaccharide;
(11) and (4) carrying out rotary evaporation and concentration on the solution of the alpha-glucan oligosaccharide obtained in the step (10), and freeze-drying to obtain the alpha-glucan oligosaccharide with the molecular weight of about 1 kDa.
2. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the alpha-D-dextranase gene in the step (1) is derived from chaetomium elegansChaetomium gracileCGMCC3.3783, the yeast is Pichia pastoris GS115, and the yeast protein expression plasmid vector is pPIC9 k.
3. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the method described in step (4)E.coli The culture medium used for the Dh5 alpha expansion culture is LB culture medium.
4. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the restriction endonuclease used for the linearization described in step (5) was ScaI.
5. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the introduction method in the step (7) is an electrical transformation method of pichia pastoris, the electric shock condition is 2000V, 200 omega and 25 muF, and the discharge time is 4.9 ms.
6. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the strain activation culture medium used in the fermentation culture in the step (8) is a yeast extract peptone glucose culture medium, YPD culture medium for short, the seed culture medium is BMGY culture medium, and the fermentation culture medium is BMMY culture medium.
7. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the centrifugation condition in the step (8) is 8000r and 10 min.
8. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the addition amount of the enzyme in the step (9) is 5U/ml, the mass concentration of the glucan is 10%, and the molecular weight of the low-molecular-weight dextran is about 8 kDa.
9. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the reaction time in the step (10) is 6 h.
10. The enzymatic method of producing α -glucan oligosaccharides according to claim 1, characterized in that: the filter membrane used in the membrane filtration in the step (10) is a filter membrane with the pore size capable of intercepting 1k of molecular weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110939430.XA CN113637716A (en) | 2021-08-16 | 2021-08-16 | Preparation method of alpha-glucan oligosaccharide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110939430.XA CN113637716A (en) | 2021-08-16 | 2021-08-16 | Preparation method of alpha-glucan oligosaccharide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113637716A true CN113637716A (en) | 2021-11-12 |
Family
ID=78422196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110939430.XA Pending CN113637716A (en) | 2021-08-16 | 2021-08-16 | Preparation method of alpha-glucan oligosaccharide |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113637716A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101638666A (en) * | 2009-04-28 | 2010-02-03 | 广州甘蔗糖业研究所 | Pichia pastoris engineered strain constructing method and dextranase preparing process |
| US20110129879A1 (en) * | 2006-04-28 | 2011-06-02 | Industry Foundation Of Chonnam National University | Hybrid Genes and Enzymes of Glucanase and Dextransucrase and Processes for Preparing Isomalto-Oligosaccharides or Dextran Using the Same |
| CN102703480A (en) * | 2012-05-10 | 2012-10-03 | 宁夏夏盛实业集团有限公司 | Alpha-glucanase, engineering bacteria and applications |
| CN113201464A (en) * | 2020-12-30 | 2021-08-03 | 广东省科学院生物工程研究所 | Pichia pastoris engineering bacteria for producing alpha-glucanase and construction method, culture method and application thereof |
-
2021
- 2021-08-16 CN CN202110939430.XA patent/CN113637716A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110129879A1 (en) * | 2006-04-28 | 2011-06-02 | Industry Foundation Of Chonnam National University | Hybrid Genes and Enzymes of Glucanase and Dextransucrase and Processes for Preparing Isomalto-Oligosaccharides or Dextran Using the Same |
| CN101638666A (en) * | 2009-04-28 | 2010-02-03 | 广州甘蔗糖业研究所 | Pichia pastoris engineered strain constructing method and dextranase preparing process |
| CN102703480A (en) * | 2012-05-10 | 2012-10-03 | 宁夏夏盛实业集团有限公司 | Alpha-glucanase, engineering bacteria and applications |
| CN113201464A (en) * | 2020-12-30 | 2021-08-03 | 广东省科学院生物工程研究所 | Pichia pastoris engineering bacteria for producing alpha-glucanase and construction method, culture method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王赟: "细丽毛壳α-葡聚糖酶的基因克隆及异源表达" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2658436C2 (en) | Method for obtaining rebaudioside m using the enzyme method | |
| JP6820924B2 (en) | How to produce psicose from fructose-containing substrates | |
| RU2737118C2 (en) | Method for producing rebaudioside n using an enzymatic method | |
| CN107501429B (en) | Method for extracting bioactive β -glucan from sparassis crispa liquid fermentation mycelium | |
| CN107686854B (en) | Method for degrading and modifying schizophyllan by utilizing endoprotease produced by schizophyllum commune fermentation system | |
| CA1088443A (en) | Method of producing polysaccharides | |
| CN110951714B (en) | Hyaluronic acid hydrolase, coding sequence thereof and method for preparing oligomeric hyaluronate by using same | |
| CN116200433A (en) | Method for preparing ergothioneine by biosynthesis of Cordyceps fungus | |
| CN109294927B (en) | Method for increasing content of cordyceps polysaccharide in cordyceps militaris | |
| CN109234220B (en) | Biological preparation strain of moisturizing repair factor glycerol glucoside and construction method and application thereof | |
| CN110541016A (en) | Extraction and purification method of lentinan | |
| CN102337313A (en) | Method for preparing trehalose | |
| CN113637716A (en) | Preparation method of alpha-glucan oligosaccharide | |
| CN113403245A (en) | Recombinant escherichia coli immobilized cell and application thereof | |
| CN112522118A (en) | Application of aspergillus versicolor in preparation of tannase and degradation of tannin | |
| CN112175098A (en) | Method for efficiently preparing polysaccharide from sparassis crispa stipe | |
| CN114766678B (en) | Extraction method of roxburgh rose flavone, spirulina instant powder and preparation method thereof | |
| CN103554287A (en) | Extraction method of boletus edulis mycelium polysaccharide | |
| CN114349806B (en) | Method for removing and purifying fucose mixture by using bacillus natto | |
| CN115161361A (en) | Method for preparing unbranched linear galactan by enzyme molecular machine technology and application | |
| CN105566510B (en) | A kind of Portugal's oligosaccharides and its preparation method and application | |
| CN111662940A (en) | Method for directionally preparing dextran | |
| CN113215206A (en) | Preparation and purification method of grifola frondosa polysaccharide with high antioxidant activity | |
| CN107141365B (en) | Method for efficiently purifying phellinus igniarius polysaccharides by repeatedly increasing and decreasing pressure | |
| CN111073921A (en) | Preparation method of heparin sodium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211112 |
|
| RJ01 | Rejection of invention patent application after publication |